COLONOSCOPY AND FLEXIBLE SIGMOIDOSCOPY- A MICROCOSTING STUDY EVALUATING DIAGNOSTIC PROCEDURAL COSTS IN AN OUTPATIENT ENDOSCOPY CLINIC

Author(s)

Jennifer C. Sambrook, MSc, Senior Health Economist1, Winnie Chui, BSc, Research Assistant1, Hong Wang, MSc, MA, Statistician1, Adrian R. Levy, PhD, Director1, Robert A. Enns, MD, Gastroenterologist21Oxford Outcomes Ltd, Vancouver, BC, Canada; 2 St. Paul's Hospital, Vancouver, BC, Canada

OBJECTIVES: With availability of several colorectal cancer screening tools, the cost-effectiveness of population-based screening programmes is of interest. The goal of this study was to estimate the per-procedure cost of conventional colonoscopy (COL) and flexible sigmoidoscopy (SIG) in an outpatient endoscopy clinic. METHODS: An activity based costing approach was carried out using time-and-motion techniques on 104 COL and 48 SIG procedures performed in St. Paul's Hospital (SPH) between July and October 2004. Observation began with patient registration in the clinic and ended with patient discharge. Direct costs, including nursing and physician time, supplies and medications, were estimated. Indirect costs included physician and pathology fees, scope repair and cleaning expenses. Hospital overhead costs were determined through SPH finance department. Total cost was calculated as the sum of direct, indirect and overhead costs. Student's t-tests were performed to determine any significant differences (P<0.10) of mean total cost between groups derived from baseline variables. Linear regression analysis of cost was also conducted. All costs are reported in 2004 Canadian dollars. RESULTS: Mean age of patients was 56 (22; 88) years for COL and 51 (17; 90) years for SIG. Mean total time was 189 (106; 317) minutes for COL and 53 (14; 111) minutes for SIG. Mean procedure time for COL and SIG was 34 (18; 61) minutes and 14 (7; 35) minutes, respectively. Total cost was $522 ($360; $679) for COL and $176 ($105; $287) for SIG. Physician and pathology fees accounted for 61% of total cost for COL and 58% for FSIG. Number of biopsies and total time have significant predictive power on total cost for both procedures. Sex and number of polypectomies are significant for COL. CONCLUSIONS: Detailed costing of such procedures provide useful estimates of health resource use which can be applied in economic evaluations of CRC screening.

Conference/Value in Health Info

2006-05, ISPOR 2006, Philadelphia, PA

Value in Health, Vol. 9, No.3 (May/June 2006)

Code

PCN19

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Gastrointestinal Disorders, Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×